The independent source for health policy research, polling, and news.
1,181 - 1,200 of 3,866 Results
An epic battle is playing out behind the scenes over whether the government should pay for Aduhelm, an FDA-approved Alzheimer’s drug that scientists say has not been proven to work.
Dr. Mai Pham left her corporate career to spark change in a system that is failing millions of Americans with autism and other intellectual and developmental disabilities.
State medical boards have an obligation to investigate complaints about doctors, including those who may spread false information about medical care. But in Florida, Tennessee, and other states, lawmakers are moving to protect physicians using unproven covid treatments or spreading misinformation.
Congress is set to start its once-every-five-years review of the law that authorizes user fees to finance the hiring of personnel to speed the FDA review of drugs. The periodic renewals of “PDUFA” also give lawmakers a chance to make other changes to the agency at the hub of the pandemic. Meanwhile, the FDA could also find itself at the center of the abortion debate and a controversial new medication to treat Alzheimer’s disease. Anna Edney of Bloomberg News, Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico, and Sarah Karlin-Smith of the Pink Sheet join KHN’s Julie Rovner to discuss these issues and more.
Among the 764 hospitals hit with a 1% reduction in Medicare payments this year for having high numbers of patient infections and avoidable complications are more than three dozen that Medicare also ranks as among the best in the country.
Investigators allege a Texas company that arranges spine surgery and other medical care for people injured in car crashes accepted bribes in violation of 1960s-era racketeering law.
A hospital in Wisconsin sued to keep seven employees from taking jobs with a competitor. A health system in South Dakota is offering nurses $40,000 signing bonuses. Facilities with fewer resources are finding it difficult or impossible to compete for health care workers.
The backroom deal with politically connected Kaiser Permanente, which infuriated other Medi-Cal health plans, allows the health care giant to continue selecting the enrollees it wants.
Home health and hospice agencies are experiencing extreme worker shortages, which means they can’t provide services to all the patients seeking care.
Some practitioners object to the way upfront cost estimates are designed, saying they could affect access to care and are burdensome. Other experts disagree.
Omicron infections are surging in residential care facilities, causing massive sickouts among staff members and an uptick in hospitalizations and deaths. The latest visitor restrictions and testing requirements are also compounding the isolation that residents have suffered for almost two years.
If federal officials accept a court’s decision, some patients will get a chance to seek refunds for their nursing home and other expenses.
Temporary subsidies helped boost enrollment under the Affordable Care Act to a record 14.5 million, according to the Department of Health and Human Services. But unless Democrats in Congress extend those subsidies, many of those new enrollees will be in for a rude surprise just ahead of midterm elections. Meanwhile, the need to replace retiring Supreme Court Justice Stephen Breyer further crowds an already tight legislative schedule. Joanne Kenen of Politico and the Johns Hopkins Bloomberg School of Public Health, Sarah Karlin-Smith of the Pink Sheet, and Anna Edney of Bloomberg News join KHN’s Julie Rovner to discuss these issues and more. Also this week, Rovner interviews Diana Greene Foster, author of “The Turnaway Study: Ten Years, a Thousand Women, and the Consequences of Having — Or Being Denied — An Abortion.”
KHN gives readers a chance to comment on a recent batch of stories.
Mass General Brigham’s $2.3 billion expansion plan is raising state officials’ concerns that it will reduce competition and raise the price of care in Massachusetts. It also signals a national shift from a focus on hospital mergers and purchases of physician practices — which boost the cost of care — to individual hospitals’ expansions to gain a bigger share of the market.
The health agency and the White House acted in the wake of a KHN story about pharmacists refusing to give shots to patients with moderate to severe immune suppression.
A KHN reporter had written for years about the people left behind by the absurdly complex and expensive U.S. health care system. Then he found himself navigating that maze as he tried to get his insulin prescription filled.
The Supreme Court temporarily blocked a federal rule requiring larger businesses to mandate employees be vaccinated or wear masks and undergo weekly testing. At the same time, however, it allowed a federal order that health care workers be vaccinated.
KHN Midwest correspondent Lauren Weber talks about the risks of covid’s spread in hospitals on the “1A” radio program and on the Newsy TV network.
As omicron sweeps the country, many hospitals are dealing with a flood of people hospitalized with covid — including those primarily admitted for other reasons. While often milder cases, so-called incidental covid infections still drain the beleaguered health care workforce and can put them and other patients at higher risk for contracting covid.
© 2026 KFF